Practice regarding antipsychotic therapy: A cross-sectional survey in two Norwegian hospitals

Nordic Journal of Psychiatry

Volumn 58, Issue 4, 2004, Pages 313-317

  Johnsen, Erik ^a   Svingen, Gard Frodahl ^b   Jørgensen, Hugo A ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Antipsychotics; Neuroleptics; Therapy practice

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; NORWAY; PRESCRIPTION; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; HEALTH SURVEYS; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTIC DISORDERS;

EID: 4544327598     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/08039480410005837     Document Type: Article

References (13)

1. Rang HP, Dale MM, Ritter JM. Neuroleptic drugs. I: Pharmacology, 3rd edition. Edinburgh: Churchill Livingstone; 1995. p. 567-75.
2. Delay J, Deniker P. Trente-Huit cas de psycoses traitées par la cure prolongée et continue de 4560 RP. Le Congrés des Al. et Neurol. de Langue Fr. I: Compte rendu du Congrés. Masson et Cie, Paris; 1952.
3. Jørgensen HA. Medikamentell behandling av schizofreni. Tidsskr Nor Lærgeforen 2002;122:2206-9.
4. Jørgensen HA. Antipsykotika. I: Vennerød AM, red. Norsk legemiddelhåndbok for helsepersonell 2001. Oslo: Foreningen for utgivelse av norsk legemiddelhåndbok; 2001. p. 806-15.
5. Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, et al. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schiz Bull 2002;28:5-16.
6. Weiden PJ, Iqbal N, Mendelowitz AJ, Tandon R, Zimbroff DL, Ross R. Best clinical practice with ziprasidone: Update after one year of experience. J Psychiat Pract 2002;8:8198.
7. Merril Lynch research estimates and IMS. Pharmaceuticals. 2001 June.
8. Weiden PJ, Casey DE. The road back: Working with those with severe mental illness, "Polypharmacy": Combining antipsychotic medications in the treatment of schizophrenia. J Prac Psych Behav Health 1999;5:229-33.
9. Miller AL, Craig CS. Combination antipsychotics: Pros, cons, and questions. Schiz Bull 2002;28:105-9.
10. Watson S, Young AH. The place of lithium salts in psychiatric practice 50 years on. Curr Opin Psychiatry 2001;14:57-63.
11. Baldessarini RJ, Tondo L, Hennen J, Viguera AC. Is lithium still worth using? An update of selected recent research. Harvard Rev Psychiatry 2002;10:59-75.
12. McIntyre RS, Mancini DA, Parikh S, Kennedy SH. Lithium revisited. Can J Psychiatry 2001;46:322-7.
13. Crow TJ. From Kraepelin to Kretschmer leavened by Schneider. The transition from categories of psychosis to dimensions of variation intrinsic in homo sapiens. Arch Gen Psychiatry 1998;55:502-4.